|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<EXCHANGE-RATE> 1
<CASH> 641
<SECURITIES> 0
<RECEIVABLES> 120,274
<ALLOWANCES> 6,876
<INVENTORY> 161,208
<CURRENT-ASSETS> 289,788
<PP&E> 101,673
<DEPRECIATION> 39,786
<TOTAL-ASSETS> 464,969
<CURRENT-LIABILITIES> 76,409
<BONDS> 353,246
0
0
<COMMON> 20
<OTHER-SE> 29,433
<TOTAL-LIABILITY-AND-EQUITY> 464,969
<SALES> 357,015
<TOTAL-REVENUES> 357,015
<CGS> 250,621
<TOTAL-COSTS> 250,621
<OTHER-EXPENSES> 8,271<F1>
<LOSS-PROVISION> (2,170)
<INTEREST-EXPENSE> 27,710
<INCOME-PRETAX> (6,432)
<INCOME-TAX> 2,637
<INCOME-CONTINUING> (8,458)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (8,458)
<EPS-BASIC> 0<F2>
<EPS-DILUTED> 0<F2>
<FN>
<F1>Product development expenses.
<F2>The Company's shares are not publicly traded.
</FN>
</TABLE>
|
|